Merops Switch to
Peptidases

Inhibitor

Family Clan Small-molecule
inhibitor SEARCHES BLAST
MEROPS

Other
information

Literature for inhibitor I04.003: kallistatin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: A Assay, T Target, K Knockout, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Lyu,J., Wang,S., Chen,J., Yang,X., Gao,G. and Zhou,T.
    The comparison of pathogenic role and mechanism of Kallistatin and PEDF in tumors
    Biochim Biophys Acta Rev Cancer (2025) 1880, 189273-189273. PubMed  Europe PubMed DOI  V
    2. 2023
  2. Wang,X., Huang,X., Gao,P., Ren,Y., Li,X. and Diao,Y.
    Kallistatin attenuates inflammatory response in rheumatoid arthritis via the NF-kappaB signaling pathway
    Eur J Pharmacol (2023) 943, 175530-175530. PubMed  Europe PubMed DOI
    3. 2022
  3. Wang,Y., Chen,X.Y., Shang,K., Xu,Q., Li,Y.X., Du,Y. and Zhuan,L.
    [Relationship of the kallistatin gene expression with male spermatogenic dysfunction and its possible mechanism]
    Zhonghua Nan Ke Xue (2022) 28, 976-984. PubMed  Europe PubMed
    4. 2021
  4. Mao,Y., Qiao,J.D., Chen,S., Zhou,X., Wang,Z., Cai,S., Li,L. and Luo,Y.
    Kallistatin Inhibits Anoikis Resistance and Metastasis of Ectopic Endometrium Cells by Modulating MnSOD and Caspase 3 Signaling
    Reprod Sci (2021) PubMed  Europe PubMed DOI
  5. Shashidhar,K.N., Lakshmaiah,V., Muninarayana,C. and Nallagangula,K.S.
    Quantitative ELISA for SERPINA4/kallistatin
    Biotechniques (2021) PubMed  Europe PubMed DOI
    6. 2020
  6. Pamukcu,O., Ay,D., Uzum,K., Barlakketi,D., Kose,M., Baykan,A., Sunkak,S. and Narin,N.
    Role of kallistatin in pediatric patients with pulmonary arterial hypertension
    Turk J Pediatr (2020) 62, 405-410. PubMed  Europe PubMed DOI
  7. Zhuan,L., Shang,K., Guan,J., Li,Y.X., Mai,X.C. and Xu,Q.
    [Expression of the kallistatin gene in rat corpus cavernosum]
    Zhonghua Nan Ke Xue (2020) 26, 223-227. PubMed  Europe PubMed
    8. 2019
  8. Wu,H., Li,R., Zhang,Z., Jiang,H., Ma,H., Yuan,C., Sun,C., Li,Y. and Kong,B.
    Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
    J Ovarian Res (2019) 12, 125-125. PubMed  Europe PubMed DOI  PMC  EPMC  T
    9. 2018
  9. Fruhbeck,G., Gomez-Ambrosi,J., Rodriguez,A., Ramirez,B., Valenti,V., Moncada,R., Becerril,S., Unamuno,X., Silva,C., Salvador,J. and Catalan,V.
    Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress
    Metabolism (2018) 87, 123-135. PubMed  Europe PubMed DOI
    10. 2017
  10. Chao,J., Li,P. and Chao,L.
    Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
    Biol Chem (2017) 398, 1309-1317. PubMed  Europe PubMed DOI  V
  11. McBride,J.D., Liu,X., Berry,W.L., Janknecht,R., Cheng,R., Zhou,K., Badiavas,E.V. and Ma,J.X.
    Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19(+) B lymphocytes in the peripheral blood
    Int J Hematol (2017) 105, 748-757. PubMed  Europe PubMed DOI
    12. 2015
  12. Lin,F., Zhou,A. and Wei,Z.
    Crystallization and crystallographic studies of kallistatin
    Acta Crystallogr F Struct Biol Commun (2015) 71, 1135-1138. PubMed  Europe PubMed DOI  E
    13. 2013
  13. Liu,X., Zhang,B., McBride,J.D., Zhou,K., Lee,K., Zhou,Y., Liu,Z. and Ma,J.X.
    Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway
    Diabetes (2013) 62, 4228-4238. PubMed  Europe PubMed DOI  K
    14. 2010
  14. Jenkins,A.J., McBride,J.D., Januszewski,A.S., Karschimkus,C.S., Zhang,B., O'Neal,D.N., Nelson,C.L., Chung,J.S., Harper,C.A., Lyons,T.J. and Ma,J.X.
    Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
    J Angiogenes Res (2010) 2, 19-19. PubMed  Europe PubMed DOI
    15. 2006
  15. Luo,L.Y. and Jiang,W.
    Inhibition profiles of human tissue kallikreins by serine protease inhibitors
    Biol Chem (2006) 387, 813-816. PubMed  Europe PubMed DOI
    16. 2003
  16. Miao,R.Q., Chen,V., Chao,L. and Chao,J.
    Structural elements of kallistatin required for inhibition of angiogenesis
    Am J Physiol Cell Physiol (2003) 284, C1604-C1613. PubMed  Europe PubMed DOI
  17. [YEAR:1-5-2003]Pimenta,D.C., Fogaca,S.E., Melo,R.L., Juliano,L. and Juliano,M.A.
    Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors
    Biochem J (1-5-2003) 371, 1021-1025. PubMed  Europe PubMed DOI  PMC  EPMC
    18. 2001
  18. Chao,J., Miao,R.Q., Chen,V., Chen,L.M. and Chao,L.
    Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling
    Biol Chem (2001) 382, 15-21. PubMed  Europe PubMed DOI
  19. [YEAR:12-1-2001]Chen,V.C., Chao,L., Pimenta,D.C., Bledsoe,G., Juliano,L. and Chao,J.
    Identification of a major heparin-binding site in kallistatin
    J Biol Chem (12-1-2001) 276, 1276-1284. PubMed  Europe PubMed DOI
  20. [YEAR:12-1-2001]Pimenta,D.C., Oliveira,A., Juliano,M.A. and Juliano,L.
    Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin
    Biochim Biophys Acta (12-1-2001) 1544, 113-122. PubMed  Europe PubMed DOI  A
    21. 2000
  21. [YEAR:22-12-2000]Chen,V.C., Chao,L. and Chao,J.
    A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein
    J Biol Chem (22-12-2000) 275, 40371-40377. PubMed  Europe PubMed DOI
  22. [YEAR:8-12-2000]Chen,V.C., Chao,L. and Chao,J.
    Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein
    J Biol Chem (8-12-2000) 275, 38457-38466. PubMed  Europe PubMed DOI
  23. [YEAR:15-6-2000]Chen,V.C., Chao,L. and Chao,J.
    Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis
    Biochim Biophys Acta (15-6-2000) 1479, 237-246. PubMed  Europe PubMed DOI
  24. Pimenta,D.C., Chen,V.C., Chao,J., Juliano,M.A. and Juliano,L.
    Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D
    J Protein Chem (2000) 19, 411-418. PubMed  Europe PubMed DOI
    25. 1995
  25. Chao,J. and Chao,L.
    Biochemistry, regulation and potential function of kallistatin
    Biol Chem Hoppe Seyler (1995) 376, 705-713. PubMed  Europe PubMed
    26. 1993
  26. [YEAR:15-11-1993]Chai,K.X., Chen,L.M., Chao,J. and Chao,L.
    Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli
    J Biol Chem (15-11-1993) 268, 24498-24505. PubMed  Europe PubMed
    27. 1992
  27. [YEAR:25-12-1992]Zhou,G.X., Chao,L. and Chao,J.
    Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence
    J Biol Chem (25-12-1992) 267, 25873-25880. PubMed  Europe PubMed
    28. 1986
  28. Chao,J., Tillman,D.M., Wang,M.Y., Margolius,H.S. and Chao,L.
    Identification of a new tissue-kallikrein-binding protein
    Biochem J (1986) 239, 325-331. PubMed  Europe PubMed  PMC  EPMC

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use